Peptide therapy, decoded.

200+ clinical monographs, interactive dosing calculators, and community reviews — all PubMed-referenced and free to access.

200+ Monographs·14 Clinical Tools·37 Languages·PubMed-Referenced·No Pharmacy Affiliations

Latest Research & Education

Article

Peptide Angio-3 Attenuates Pulmonary Fibrosis Via Modulation of Coagulation Factor Xa-PAR-1 Signaling Axis

Angio-3, a 10-residue peptide derived from human plasminogen kringle 3, demonstrated significant antifibrotic activity in pulmonary fibrosis models by functioning as a PAR-1 antagonist that disrupts the coagulation factor Xa-PAR-1 signaling axis. The peptide inhibited fibroblast invasion and migration with a favorable safety profile—no adverse effects at 0.5 mg/kg/day and only mild hepatomegaly at supratherapeutic doses.

Peptide Publicus Editorial··1 min read
Evidence-based
Guides

펩타이드는 안전한가: 임상 연구 결과

펩타이드 의약품의 안전성을 임상 연구 데이터로 검증합니다. GLP-1 수용체 작용제, BPC-157, 항균 펩타이드 등 주요 펩타이드의 부작용 프로파일과 MFDS 규제 현황, 한국 임상시험 결과를 종합 분석한 안전성 가이드입니다.

Peptide Publicus Editorial··5 min read
Evidence-based
Review

Antimicrobial Peptides Show Promise as Cancer Therapeutics: A 2026 Systematic Review

A new review in Frontiers in Medicine evaluates antimicrobial peptides (AMPs) as anticancer agents, finding selective cytotoxicity against tumor cells via membrane disruption and apoptosis induction, though clinical evidence remains limited to early-phase trials.

Peptide Publicus Editorial··2 min read
Evidence-based
Article

Pemvidutide Achieves MASH Resolution in Phase 2b IMPACT Trial

The Lancet published Phase 2b results for pemvidutide, a dual GLP-1/glucagon agonist, showing significant MASH resolution without worsening fibrosis at 24 weeks. FDA granted Breakthrough Therapy designation in January 2026.

Peptide Publicus Editorial··2 min read
Evidence-based
Article

Retatrutide Achieves 28.7% Weight Loss in TRIUMPH-4 Phase 3 Trial

Eli Lilly's triple GIP/GLP-1/glucagon agonist retatrutide achieved an average 28.7% body weight reduction at 68 weeks in the pivotal TRIUMPH-4 trial — the largest weight loss ever reported for any anti-obesity medication in Phase 3.

Peptide Publicus Editorial··2 min read
Evidence-based
Informational

펩타이드란 무엇인가: 체내 작동 원리 완전 가이드

펩타이드는 아미노산이 펩타이드 결합으로 연결된 짧은 사슬 분자로, 호르몬·신경전달물질·항균물질 등 다양한 생체 기능을 수행합니다. 이 글에서는 펩타이드의 정의, 체내 합성 과정, 수용체 결합 메커니즘, 주요 생리 기능, 한국 MFDS 규제 현황, 그리고 임상 응용까지 총정리합니다.

Peptide Publicus Editorial··4 min read
Evidence-based

Real Experiences from Real UsersNEW

BPC-157
Worth it

Game-changer for my knee recovery

After 6 weeks of subcutaneous injections, the chronic tendon pain I'd had for 2 years was down to almost nothing. Combined with PT, the results were remarkable.

Verified user · 8 weeks

Semaglutide
Worth it

Steady weight loss, minimal sides

Lost 14 lbs over 3 months on the titration schedule. Nausea was real the first 2 weeks but manageable. Worth it for the appetite control alone.

Verified user · 12 weeks

CJC-1295 + Ipamorelin
Worth it

Best GH stack I've tried

Noticeably better sleep by week 2, improved recovery from training by week 4. Skin quality improved. No water retention like with GHRP-6.

Verified user · 16 weeks

200+

Monographs

14

Interactive Tools

37

Languages

100%

Independent

최신 소식을 받아보세요

임상 업데이트, 산업 뉴스, 새로운 연구 요약 및 도구 출시 소식.

개인정보를 존중합니다. 언제든지 구독을 취소할 수 있습니다.